Tobacco Dependence: Clinical Trials

7 trials for Tobacco Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 22Completed 2

Follow Tobacco Dependence: new trials by email Literature Review of Tobacco Dependence trials Research Report on Tobacco Dependence

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CO Monitoring for Tobacco Cessation in Quitlines
Quitline Treatment as Usual (TAU), Remote Carbon Monoxide (CO) Monitoring, Incentivized Remote CO Monitoring - Tobacco Dependence
Phase 1 / Phase 2CompletedConsumer Wellness Solutions2292021-12-312024-10-28
Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and NicoretteĀ® Mint Gum in Healthy Smokers
Nicorette Extra Mint 2 mg Gum, Nicorette Mint 2 mg Gum, Nicorette Extra Mint 4mg Gum - Tobacco Dependence
Phase 1CompletedMcNeil AB762017-08-142019-01-03
A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.
Nicorette Strongmint lozenge 4 mg, Niquitin MiniMint lozenge 4 mg - Tobacco Dependence
Phase 1CompletedMcNeil AB2442017-03-202018-07-27
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
Web-Based Tailored Smoking Cessation Intervention, Standard of Care - Tobacco Use Cessation, Tobacco Cessation
Phase 1 / Phase 2CompletedGeorgetown University1382011-09-012014-05-12
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
Anatabloc(TM), CigRx(R) - Tobacco Use Disorder, Tobacco Dependence
Phase 1CompletedRock Creek Pharmaceuticals, Inc.1092011-09-012015-10-30
Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products
Nicotine - Tobacco Dependence
Phase 1CompletedMcNeil AB502011-02-012012-07-10
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
Bupropion SR - Nicotine Dependence, Tobacco Dependence
Phase 1CompletedCentre for Addiction and Mental Health502005-06-012013-02-15

Narrower conditions

Tobacco Use Disorder (7)  ·  Tobacco Use Cessation (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Smoking (1)  ·  Smoking Cessation (1)

Broader conditions

Chemically-Induced Disorders (7)  ·  Mental Disorders (7)  ·  Substance-Related Disorders (7)  ·  Behavior (4)  ·  Health Behavior (3)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)

Interventions

Chewing Gum (1)  ·  Nicotine (1)  ·  Standard of Care (1)

Sponsors

McNeil AB (3)  ·  Centre for Addiction and Mental Health (1)  ·  Consumer Wellness Solutions (1)  ·  Georgetown University (1)  ·  Rock Creek Pharmaceuticals, Inc. (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)  ·  Russia (1)  ·  Sweden (1)

Top investigators

Elena P Mazygula, MD (1)  ·  Elisabeth Kruse, PhD (1)  ·  Kelly Carpenter, PhD (1)  ·  Maria Varga, MD (1)  ·  Peter Selby, MD (1)  ·  Shi Aixin, M. Pharm (1)

Results publications

PMID 25118794, PMID 27215559

NIH funding

R21CA163100 (1)